Previous Article | Next Article 
Infection and Immunity, October 1998, p. 4838-4844, Vol. 66, No. 10
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Toxoplasma Gondii Bradyzoites Form
Spontaneously during Sporozoite-Initiated Development
M. E.
Jerome,1
J. R.
Radke,1
W.
Bohne,2
D. S.
Roos,2 and
M. W.
White1,*
Veterinary Molecular Biology, Montana State
University, Bozeman, Montana,1 and
Department of Biology, University of Pennsylvania,
Philadelphia, Pennsylvania2
Received 27 January 1998/Returned for modification 17 April
1998/Accepted 21 July 1998
 |
ABSTRACT |
Tachyzoites (VEG strain) that emerge from host cells infected with
Toxoplasma gondii sporozoites proliferate relatively fast and double their number every 6 h. This rate of growth is
intrinsic, as neither the number of host cells invaded nor host cell
type appears to influence emergent tachyzoite replication. Fast
tachyzoite growth was not persistent, and following ~20 divisions,
the population uniformly shifted to slower growth. Parasites 10 days
post-sporozoite infection doubled only once every 15 h and, unlike
emergent tachyzoites, they grew at this slower rate over several months
of continuous cell culture. The spontaneous change in tachyzoite growth
rate preceded the expression of the bradyzoite-specific marker,
BAG1. Within 24 h of the growth shift, 2% of the
population expressed BAG1, and by 15 days post-sporozoite
infection, 50% of the parasites were positive for this marker.
Spontaneous BAG1 expression was not observed in sporozoites
or in tachyzoites during fast growth (through day 6 post-sporozoite
inoculation), although these tachyzoites could be induced to express
BAG1 earlier by culturing sporozoite-infected cells at pH
8.3. However, alkaline treatment also reduced the replication of
emergent tachyzoites to the rate of growth-shifted parasites,
supporting a link between reduced parasite growth and bradyzoite
differentiation. The shift to slower growth was closely correlated with
virulence in mice, as the initially fast-growing emergent tachyzoites
were avirulent (100% lethal dose, >104 parasites), while
a mutant VEG strain (MS-J) that is unable to growth shift caused 100%
mortality in mice inoculated with 10 parasites. Parasites recovered
from gamma interferon knockout mice inoculated with emergent
tachyzoites grew at a slow rate and expressed BAG1,
confirming that the replication switch occurs in animals and in the
absence of a protective immune response.
 |
INTRODUCTION |
Toxoplasma gondii has a
complex life cycle involving two different host types and cycles
(reviewed in reference 9). The definitive (sexual)
cycle commences when bradyzoites (tissue cysts) infect epithelial cells
of the feline intestine and differentiate into the first of a series of
merozoite generations (7). Only the bradyzoite stage is
capable of initiating the definitive cycle of T. gondii
(9) and the equivalent cycles of other cyst-forming coccidians, including Hammondia spp. and
Sarcocystis spp. (6). It is intriguing, however,
that the interaction of bradyzoite and definitive host, which is
exclusive in these closely related coccidians, is nonspecific in
T. gondii. T. gondii tissue cysts are infectious for a wide
array of other animal hosts, and in these hosts, as well as
extraintestinally in the cat, bradyzoites develop into tachyzoites
which eventually will reform cysts, thus completing the intermediate
host cycle (9). Although the differences between these
coccidians are well known, it remains unclear what parasite factors
allow T. gondii bradyzoites to initiate a second cycle that
in Hammondia and Sarcocystis is solely a function
of the sporozoite stage (6).
The unique ability of T. gondii bradyzoites and tachyzoites
to interconvert is clinically important, as it is considered to be the
underlying cause of Toxoplasma encephalitis in AIDS patients (21). The slow-growing T. gondii bradyzoite is
relatively nonpathogenic and not readily eliminated by the host immune
system. Thus, in immunodeficient or -compromised hosts, recurrent
toxoplasmosis can occur each time latent bradyzoites recrudesce into
proliferating tachyzoites. The mechanism that controls T. gondii tachyzoite-to-bradyzoite development is of obvious
importance and is currently the subject of some controversy. In
vitro, high-temperature or alkaline-pH stress (30) and
inhibitors of parasite DNA synthesis or mitochondrial function
(2) all induce bradyzoite antigen expression in
tachyzoites. Thus, it is proposed that tachyzoite-to-bradyzoite
differentiation may be host induced and that host cytokines could
mediate induction in vivo (1, 25). If this model is
accurate, it remains to be explained why some tachyzoite strains are
able to differentiate in culture in the absence of any obvious
inductive agents (20, 29).
Like bradyzoites, T. gondii sporozoites are infectious to
definitive and intermediate hosts, although in either host type they
are restricted to initiating the intermediate host cycle (9,
14). Sporozoites invade host cells, and for 24 h or less they occupy a temporary parasitophorous vacuole where they
differentiate into tachyzoites (32-34). Parasite
replication begins when the developing tachyzoites move from the
transient vacuole into a second parasitophorous vacuole that contains
the structures necessary to support parasite growth (32,
34). In this report, we extend our studies of T. gondii sporozoite development by following the growth and
stage-specific protein expression of tachyzoites formed by sporozoite
infection. Our results show that emergent tachyzoites undergo a rapid
but limited expansion that precedes their spontaneous differentiation
into bradyzoites.
 |
MATERIALS AND METHODS |
Cell culture and parasite strains.
Human foreskin
fibroblasts (HFF) were grown in Dulbecco's modified Eagle medium
(DMEM) supplemented with 10% (vol/vol) newborn calf serum. Sporulated
oocysts from an avirulent strain (VEG) of T. gondii
originally isolated from an AIDS patient (23) were purified
from cat feces by centrifugal elutriation as described previously
(33). Purified oocysts were incubated in 10% (vol/vol) Clorox (in phosphate-buffered saline [PBS]) at room temperature for
30 min, collected by centrifugation, and washed 3 to 4 times in Hanks'
balanced salt solution (GIBCO, Gaithersburg, Md.) to remove residual
Clorox. Sporozoites were excysted according to published methods
(31), washed in PBS, and in some cases, filtered through
3-µm-pore-size polycarbonate filters (Nucleopore Corp., Pleasanton,
Calif.) to remove sporocysts, unbroken oocysts, and oocyst debris.
Sporozoites were suspended in culture medium containing 1% fetal
bovine serum or newborn calf serum, 50 µg of dihydrostreptomycin per
ml, and 50 U of penicillin G per ml, and inoculated into cultured cells. Sporozoite-infected cultures were shifted to alkaline conditions by replacing the standard growth medium with a Tricine (45 mM)-buffered DMEM adjusted to pH 8.3 with KOH and incubating the cultures in a
CO2-free environment throughout the experiment.
Tachyzoite strains RH and ME49-P(lk) were maintained in confluent
monolayers of HFF cells according to standard protocols (26). Emergent VEG tachyzoites were obtained from cultures
of HFF cells inoculated with sporozoites. Mutant VEG strain MS-J arose
spontaneously from a sporozoite-infected culture that was continuously
passaged in HFF cells for over 4 months. The growth rate and virulence
of MS-J tachyzoites have been stable for over a year in culture.
RFLP analysis.
Strains RH, ME49-P(lk), and VEG represent
type strains for lineages I, II, and III, respectively (15).
Allelic differences were evaluated at the SAG1 and
SAG2 loci for these strains and mutant line MS-J by
restriction fragment length polymorphisms (RFLPs) in single-copy DNA
segments amplified by PCR (for primer designs, see reference
15). Gel-purified PCR product obtained with the SAG1
primers was digested with enzyme DdeI or Sau96I (New England BioLabs, Beverly Mass.), and the fragments were analyzed on 1.2% agarose gels. Similarly, analysis of the SAG2 locus
was completed with Sau3A. RFLPs were evaluated by comparison
of their size to a standard DNA ladder (
x174/HaeIII,
GIBCO).
Determination of parasite growth rates.
To measure
replication rates, HFF monolayers infected with tachyzoites at mid-log
growth (4 to 32 parasites per vacuole) were scraped, passed through a
25-gauge needle, and filtered through 3-µm-pore-size polycarbonate
filters. The filter-purified tachyzoites were inoculated into a fresh
HFF culture (25 cm2 T-flask), incubated for 1 h at
37°C to allow parasite penetration, and then washed with standard
growth medium to remove extracellular tachyzoites, whereupon the
incubation was continued. At various time intervals, the vacuole size
(1, 2, 4, 8, 16, 32, 64 tachyzoites per vacuole) within a single T-25
flask was determined for a minimum of 50 vacuoles (5 to 10 fields at
×400) chosen at random without prior microscopic examination. The
average parasite number per vacuole and standard deviation were
calculated for each time point.
Experimental infections in mice.
Female CD-1 outbred mice
and mice containing a targeted disruption of the gamma interferon gene
(gko) (5) were used for experimental infections. Parasite
inoculum (101 to 105) was purified from
tachyzoite- or sporozoite-infected HFF cell monolayers as described
above. At the appropriate parasite dose, five mice were infected by
subcutaneous (s.q.) inoculation and monitored for 30 days, at which
time the sera of surviving mice were analyzed by immunofluorescence
assay (see next section). Serum exhibiting a >1:100 titer was
considered confirmation of a Toxoplasma infection.
To assess the growth rate of parasites passed in mice, gko mice were
inoculated s.q. with 10
3 MS-J tachyzoites or VEG
tachyzoites from HFF cultures at 3 or
8 days post-sporozoite infection.
The mice were euthanized 10
days postinoculation, the brain tissue was
homogenized in HFF
cell culture media, and 0.1 ml of the suspension was
inoculated
intraperitoneally into a second gko mouse. The peritoneal
exudate
of the second gko mouse was removed 7 days postinoculation and
inoculated into HFF cultures. After a single passage, growth rate
and
percent
BAG1 expression of the isolated parasite populations
were evaluated (see next section).
Immunofluorescence assays.
HFF cells grown in 8-well chamber
slides or on 6-well plates containing coverslips were inoculated with
105 sporozoites or tachyzoites. At various intervals, the
slides were washed three times in PBS, fixed with 3% paraformaldehyde in PBS, treated in acetone for 10 min at 4°C, and air dried. The slides were incubated with anti-recombinant BAG1 mouse antiserum (3) or anti-SAG1 monoclonal antibody DG52 (4) for
1 h in a humid chamber and then washed three times in PBS followed
by a single wash in PBS-1% bovine serum albumin (wt/vol). Matched irrelevant antibody controls were included for each antibody. The
slides were treated with secondary antibody fluorescein-conjugated anti-mouse immunoglobulin G (IgG) (Sigma, St. Louis, Mo.) diluted 1:64
in DMEM containing 2.5% goat sera for 1 h in the dark, washed four times in PBS, mounted with Gel-mount solution containing 2.5%
(wt/vol) diazabicyclo[2.2.2.7]octane, and evaluated with a
Nikon epifluorescence microscope. BAG1-positive parasites
were enumerated by examining at least 100 vacuoles in randomly selected fields.
 |
RESULTS |
Tachyzoites emerging from sporozoite-infected cells undergo a
change in growth rate.
To measure the growth rate of VEG
tachyzoites emerging from sporozoite-infected HFF cells (emergent
tachyzoites), sporozoite cultures were disrupted by needle passage (48 h postinoculation), and tachyzoites were filter purified and
reinoculated into a fresh HFF cell monolayer. Parasite growth was
monitored by counting the number of tachyzoites per vacuole at 12-h
intervals. Tachyzoites within a vacuole exhibit exponential growth, and
by limiting the infection period (1 h), the range of vacuole sizes
during growth was tightly distributed (11). Emergent
tachyzoites doubled on average every 6 h and lysed their host
cells (at 64 to 128 parasites per vacuole) beginning 48 h
postinoculation (Fig. 1A, closed bars). The emergent replication rate and rapid expansion period were limited,
however. Ten days after the establishment of a tachyzoite-infected culture from sporozoites (Day 10 VEG tachyzoites), the parasite growth
rate had dramatically slowed (Fig. 1A) and host lysis (4 to 5 days) was
significantly delayed. Whereas emerging tachyzoites divide
approximately once every 6 h, the growth rate of day 10 VEG
tachyzoites (Fig. 1A, hatched bars) was two- to threefold slower (~15
h doubling). Once growth shifted, tachyzoites did not resume a fast
growth rate through 3 months of continuous culture.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Growth of VEG tachyzoite populations obtained
following sporozoite inoculation. The day 10 population was purified
after a single passage (at 5 days post-sporozoite inoculation) into a
second HFF monolayer. The day 2 (closed bars) and day 10 (hatched bars)
VEG parasites were allowed to invade confluent HFF monolayers for
1 h before extracellular parasites were removed. Vacuole sizes
(number of parasites per vacuole) were determined every 12 h over
48 h. All growth data represent the average of at least 50 randomly selected vacuoles and are plotted on a log10
scale. (B) Rapid growth of emergent tachyzoites is stable for 5 days
and is not limited by the number of host cell invasions. Beginning at
48 h post-sporozoite inoculation, purified tachyzoites were
inoculated into fresh HFF monolayers (1 h infection), and the average
vacuole size was determined 24 h later. This process was repeated
every 24 h through five host cell passages (see Materials and
Methods for complete details). The vacuole size in host cell passage
no. 1 represents tachyzoite growth within the sporozoite-infected host
cell (24 to 48 h post-sporozoite inoculation).
|
|
In order to follow the growth rate of emergent tachyzoites beyond a
single infectious cycle, parasites were passed (prior
to host cell
lysis) into new HFF cell monolayers at 24-h intervals
over 7 days.
Beginning with sporozoite-infected cells (Fig.
1B,
host cell 1, growth
was monitored 24 to 48 h postsporozoite) and
continuing through
the fifth host cell, tachyzoites grew at the
emergent rate of three to
four divisions in a 24-h period (Fig.
1B, host cell 1 to 5), but by the
sixth host cell (day 7 postinoculation),
the growth of the population
as a whole was dramatically slower
(Fig.
1B, host cell 6). Whether
tachyzoites were passed less frequently
(every 36 or 48 h) or
sporozoites were inoculated sparsely to
avoid exhausting the initial
HFF monolayer, a reduced rate of
parasite growth appeared in a similar
time frame in each case
(data not shown).
Change in tachyzoite growth rate precedes a spontaneous
switch to bradyzoite development.
The induction of
bradyzoite differentiation by drug treatments or physiological
stress leads to a concomitant reduction in the growth rate of the
affected tachyzoites (2, 30). We therefore examined whether
the spontaneous shift of emergent tachyzoites to slower growth was
associated with a switch to bradyzoite development. To assess
bradyzoite differentiation, antiserum prepared against recombinant bradyzoite-specific antigen 1 (BAG1) (3) was
used in an immunofluorescent assay to identify differentiating
parasites. BAG1 expression was not observed in
sporozoites (data not shown) (3) or during rapid growth of
emergent VEG tachyzoites. BAG1 expression was detected,
however, following the shift in growth rate as demonstrated by the
results shown in Fig. 2. VEG tachyzoites from day 4 post-sporozoite cultures were reinoculated into a new monolayer, and the vacuole size and the frequency of
BAG1-positive parasites were determined 24 h later
(Fig. 2, day 5). As noted, tachyzoites at this stage grow at the fast
rate (three to four divisions/24 h, see Fig. 1B), and examination under
fluorescence did not reveal BAG1-positive parasites here or
at earlier times post-sporozoite infection (percent BAG1 is
denoted by the closed squares). In the next passage (day 6, see arrow),
tachyzoite growth was slowed (Fig. 2, day 7), in agreement with our
previously established time frame (Fig. 1B), and we observed a small
fraction (2%) of parasites staining positive for BAG1. The
frequency of BAG1 parasites increased in the next passage
(10%, day 9) and continued to rise (14.6%, day 10), reaching a
maximum of ~50% by 15 days post-sporozoite inoculation.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 2.
BAG1 expression is detected following a
reduction in tachyzoite growth rate. VEG tachyzoites purified from days
4, 6, and 8 (arrows) post-sporozoite inoculation cultures were passed
into fresh HFF monolayers, and 24 h later the average vacuole size
and number of BAG1-positive parasites were evaluated (see
Materials and Methods). Hatched bars, average vacuole size; closed
squares, percentage of BAG1-positive parasites.
|
|
Figure
2 indicates that lengthening of the tachyzoite cell cycle is
closely correlated with the bradyzoite development. We
were interested,
therefore, in whether emergent VEG tachyzoites
could be induced to
differentiate. Sporozoite-infected HFF cultures
were changed to
alkaline media (pH 8.3) 12 h postinoculation,
and the growth rate
and frequency of
BAG1 expression were followed
over 96 h (Fig.
3). Sporozoite development into
tachyzoites did
not appear to be affected by the alkaline culture
conditions;
they moved from the first into the second parasitophorous
vacuole
by 24 h postinoculation, and the induction of the
tachyzoite-specific,
SAG1 antigen followed established
kinetics (data not shown) (
33,
34). Emergent tachyzoites
cultured in pH 7 medium do not express
BAG1 and begin to
lyse from sporozoite-infected host cells by
72 h (Fig.
3, closed
squares). In contrast, parasites shifted
to alkaline conditions (Fig.
3, closed circles) grew at a slow
rate, equivalent to that of
growth-shifted tachyzoites (Fig.
1A,
hatched bars).
BAG1-positive parasites were clearly present in
the alkaline
cultures by 72 h postinoculation, and nearly 50%
of the parasites
were expressing
BAG1 at 96 h (Fig.
3, hatched
bars).
Thus, emergent tachyzoites have the capacity to differentiate
into
bradyzoites within 48 h of their forming in the
sporozoite-infected
cell (

24 h postinoculation).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Tachyzoites formed within sporozoite-infected cells can
be induced to express BAG1. Sporozoite-infected cultures
were switched to alkaline medium 12 h postinoculation. The average
vacuole size (pH 8.3, closed circles) and number of
BAG1-positive parasites (hatched bars) were then determined
over 96 h and compared to those obtained with control cultures (pH
7 growth, closed squares). BAG1 expression was not detected
in control parasites, which had completely lysed out of their host
cells by 96 h post-sporozoite infection.
|
|
The spontaneous switch to slow growth and bradyzoite
differentiation occurs in vivo and influences virulence in mice.
A
fast-growing tachyzoite line (MS-J) was established by continuous
passage of a sporozoite-infected culture. The MS-J tachyzoite growth
rate (~7 h, doubling time is estimated from growth curves not shown)
is similar to that of day 2 (postsporozoite) VEG tachyzoites (Fig. 1A,
~6 h) and somewhat slower than that of tachyzoites of the RH strain
(~4.5 h). Inoculated s.q. into CD-1 mice, MS-J and RH tachyzoites
caused 100% mortality at parasite doses of
101 (only
103 dose is shown [Fig.
4]). Doses of fewer than 10 parasites
were not attempted; however, we noted that the time to death of CD-1 mice infected with the faster growing RH strain (closed circles) was
consistently shorter than that of MS-J-infected mice, which likely
reflects a higher virulence (16).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Tachyzoites obtained from VEG sporozoite-infected
cultures are avirulent in CD-1 mice. The virulence of day 3 and day 8 (post-sporozoite infection) VEG tachyzoite populations was compared to
that for RH (closed squares) and MS-J (closed triangles) tachyzoite
lines. CD-1 mice (groups of 5) were inoculated s.q., and mortality was
monitored over 30 days (only 22 days are shown). The results obtained
from a 103 parasite dose are displayed. CD-1 mice infected
with emergent VEG tachyzoites were asymptomatic, although all showed
positive serology to T. gondii, indicating that they were
infected.
|
|
Acute virulence of
T. gondii type 1 strains (
28),
and some natural recombinants (
16), is correlated with
allele 1 of the
SAG1 locus, while avirulent strains, such as
the type III VEG
strain, usually have the
SAG1-2 allele
(
15,
23). Accordingly,
we eliminated the possibility that
MS-J arose from a contamination
event. Results of RFLP analyses
performed on PCR-amplified DNA
are shown in Fig.
5. Strains ME49-P(lk), VEG, and the
mutant MS-J
display identical alleles at the
SAG1 locus,
consistent with avirulence
in mice (only the
DdeI digest is
shown, lanes 2 to 4, Fig.
5),
while the allele for RH is distinct for
virulent strains (Fig.
5, lane 1) (
15,
16). At the
SAG2 locus, RFLP patterns for
VEG and MS-J are identical as
expected (Fig.
5, lanes 7 and 8),
while those for RH and ME49-P(lk) are
distinct (Fig.
5, lanes
5 and 6). These data serve to illustrate the
authenticity of the
type I, II, and III clonal lineages (
15)
used in this comparison
and demonstrate the avirulent genotype of the
mutant MS-J at
SAG1.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 5.
RFLP analysis of MS-J parasites. Restriction enzyme
patterns of the SAG1 (DdeI digest shown, lanes 1 to 4) and
SAG2 (Sau3A shown, lanes 4 to 8) loci from RH, ME49-P(lk),
VEG, and the VEG mutant MS-J are shown. Genomic DNAs were PCR
amplified, the products were restricted, and the fragments were
resolved on 1.2% agarose gels. Lanes: 1 and 5, RH; 2 and 6, ME49-P(lk); 3 and 7, VEG; 4 and 8, MS-J. Molecular size standards are
from HaeIII-digested x174 DNA.
|
|
In contrast to the acute virulence of MS-J and RH, CD-1 mice survived
infections with >10
4 day 3 or day 8 (postsporozoite) VEG
tachyzoites (10
3 dose shown, Fig.
4). In all surviving
mice, infections were confirmed
by a positive immunofluorescent assay
result. It may be inferred
from these results that the fast growth of
day 3 VEG tachyzoites
is limited and therefore that these parasites
pose no more of
a threat to an immunocompetent animal than the
growth-shifted
day 8 VEG tachyzoites. We explored this question further
in gko
mice, whose defective immune system is unable to eliminate
infections
with avirulent strains (
27). The virulence
studies in gko mice
were performed twice with identical results, and
the results of
one experiment are shown in Fig.
6 (10
3 doses shown). In gko
mice, all strains tested were lethal, with
the time to death
correlating with the relative differences in
their respective growth
characteristics. As expected, gko mice
infected with RH (open circles)
and MS-J (closed squares) tachyzoites
succumbed in the shortest time,
whereas some mice inoculated with
day 8 VEG parasites (open squares)
survived nearly a week longer.
Because day 3 VEG tachyzoites (closed
triangles) grow fast initially
and then shift to slower growth, the
time to death of mice infected
with these parasites fell between the
MS-J and day 8 VEG parasites.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
Tachyzoite growth differences are consistent with the
time to death for infected gko mice. RH (open circles), MS-J (closed
squares), and day 3 (closed triangles) and day 8 (open squares) VEG
tachyzoites were inoculated (103 parasites) s.q. into gko
mice (groups of five), and mortality was monitored. Mock-infected
controls (closed circles).
|
|
In order to confirm that day 3 VEG tachyzoites had growth shifted in
the gko mice, parasites were obtained from the brain
tissue of gko
infected mice and reinoculated intraperitoneally
into new gko mice to
expand the parasite population. The peritoneal
exudate was then
removed, and the recovered parasites were passed
once in HFF cells
before evaluating their growth rate (Fig.
7).
The time from sporozoite (or MS-J
tachyzoite) inoculation until
the parasites were reestablished in cell
culture was 17 days.
Tachyzoites obtained from animals infected with
day 3 VEG tachyzoites
(Fig.
7, day 3A) grew approximately threefold
more slowly than
the starting parasite population (day 3B), indicating
that they
had shifted their growth in the gko mice. Because day 8 VEG
tachyzoites
had already growth shifted in cell culture, the phenotype
of parasites
recovered from gko mice was unchanged (day 8B, A). The
growth
behavior of the mutant MS-J, which does not growth shift, was
also unaltered by passage in gko mice (MS-JA, B). Spontaneous
BAG1 expression was readily detected (>10%) in the
parasite populations
recovered from day 3 or day 8 mice, indicating
that the switch
to bradyzoite differentiation had also occurred in
these animals
(data not shown). MS-J tachyzoites did not express
BAG1 before
or after passage through gko mice, in agreement
with our inability
to detect tissue cysts in CD-1 mice infected with
MS-J parasites.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 7.
Fast-growing, emergent tachyzoites display a slower
growth rate after passage in gko mice. Day 3 and day 8 post-sporozoite
infection and MS-J (VEG) tachyzoites (103 parasites) were
inoculated s.q. into gko mice. Infected brain tissue (10 days
postinfection) was inoculated intraperitoneally into new gko mice, and
after a period of amplification (7 days), parasites were recovered from
the peritoneal exudate. Upon first passage into fresh HFF cells,
vacuole sizes were determined 36 h postinoculation (see Materials
and Methods for complete details). Closed bars (B), 36 h vacuole
size prior to passage through mice; hatched bars (A), vacuole size
post-gko passage.
|
|
 |
DISCUSSION |
Soon after host cell invasion, VEG sporozoites begin to
differentiate, as evidenced by the concurrent induction of
tachyzoite-specific (33, 34) and the disappearance of
sporozoite-specific proteins (17). On the basis of these
examinations, the parasites that release from sporozoite-infected cells
do not appear to express sporozoite proteins and are therefore
undifferentiated tachyzoites. Emergent tachyzoites grow uniformly and
at a relatively fast rate in different host cell types (HFF cells, Fig.
1A and B). Remarkably, however, this rate of growth was proscribed to
~20 parasite divisions in three (6 to 7 divisions/cell) to five host
cells (24-h passage; Fig. 1B), indicating that emergent tachyzoite
growth is somehow restricted by a mechanism that is unrelated to host
cell invasion. It is unlikely that this growth limit is due to a cell
culture deficiency, because rapidly dividing VEG tachyzoites develop
directly from sporozoites in vitro (Fig. 1A, day 2 tachyzoites), and
fast growth was not sustainable and slow growth was not reversible when
various tachyzoites were introduced into mice (compare days 3 and 8, Fig. 7). It is conceivable that the spontaneous slowing of emergent VEG
tachyzoite growth reflects a cell cycle regulatory mechanism that may
limit the biotic potential of sporozoite infections.
The appearance of parasites expressing bradyzoite antigen,
BAG1, occurred only subsequent to a reduction in VEG
tachyzoite growth rate (Fig. 2 and 3). Thus, lengthening of the
tachyzoite cell cycle in vitro is correlated with bradyzoite
development. A similar connection between tachyzoite growth rate and
stage conversion was noted in earlier attempts to induce
differentiation (2). However, in contrast to the conclusions
offered by these studies, our results demonstrate that following the
fast growth period, VEG tachyzoite differentiation was spontaneous
(Fig. 2), indicating that these events are most likely genetically
controlled rather than host induced. A delay in VEG tachyzoite in vitro
differentiation is consistent with the reported time lag (7 to 10 days)
between T. gondii oocyst infection and the appearance of
functional bradyzoites in various mouse tissues (M-7741 and VEG
strains) (8, 10). Thus, the VEG strain used here is
developmentally competent, although we have not tested in
vitro-produced VEG bradyzoites in the feline bioassay (10).
Cumulatively, the duration of sporozoite differentiation (
24 h)
(10, 32, 33) combined with the estimated interval for
tachyzoite to bradyzoite conversion (~2 days) (8, 22) is
insufficient to account for this delay. Indeed, our results appear to
confirm this minimal time frame, since BAG1 was detectable within 48 h (72 h postsporozoite; Fig. 3) of tachyzoite formation (24 h postsporozoite) in alkaline-treated sporozoite cultures. Despite
these results, BAG1-positive parasites were not apparent in
mouse intestine (BAG1=BAG5; see reference 10) and
were absent from uninduced VEG tachyzoite cultures (Fig. 2) until >5
days post-sporozoite infection. Thus, even though newly formed
tachyzoites have the capacity to differentiate in vitro, the extent of
the bradyzoite delay in oocyst-infected mice seems to support the hypothesis that tachyzoites inherently expand before they
differentiate. It is not known if bradyzoite infections of mice are
governed by similar mechanisms. On the basis of the cat bioassay,
bradyzoites reappear in tissue cyst-infected mice in a delayed fashion
that is remarkably similar (7 to 9 days) (8) to sporozoite
infections. There are also data indicating that, like sporozoites
(33, 34), bradyzoites transform quickly into tachyzoites
without parasite replication being required (1, 29). It is
intriguing to speculate, based on this evidence, that the intermediate
cycle of T. gondii in mice may be similarly presented,
regardless of whether infection is initiated by sporozoites or
bradyzoites.
The growth constraint of emergent VEG tachyzoites appears to be a brake
that can be lost, as exemplified by the mutant strain MS-J. MS-J
tachyzoites grow nearly as fast as emergent VEG tachyzoites, but their
growth was unaffected by long-term cell culture or passage in mice
(Fig. 7). Accordingly, MS-J tachyzoites caused 100% mortality in CD1
mice at a dose more than 3 orders of magnitude lower than that of
either emergent or growth-shifted VEG tachyzoites (Fig. 4). The
specific mutation in MS-J parasites is unknown; however, MS-J is
identical to its avirulent, type III parent at the SAG1 locus (Fig. 5) (23), thereby ruling out an obvious virulence marker (16, 28). Although it is possible that a mutation
other than one affecting growth is responsible for MS-J virulence, the correlation between the time of mortality and the relative growth differences of the various tachyzoite strains tested (compare RH to
MS-J in CD-1 mice, Fig. 4; see gko mice, Fig. 6) suggests that growth
rate and the capacity to growth shift are virulent determinants. The
connection between T. gondii virulence and elevated multiplication rate has long been recognized (18, 19), as has the role of continuous parasite culture or passage in mice in
selecting tachyzoites with higher virulence (13, 16). The importance of the studies shown here is the discovery that emergent VEG
tachyzoites have a naturally rapid growth rate, albeit of limited
duration. The loss of this regulatory mechanism, which may readily
occur when tachyzoites are removed from their natural developmental
context, could explain some of these virulent strains.
Our ability to resolve questions about the T. gondii cell
cycle and its relationship to development and the acquisition of virulence is hampered by a lack of experimental models. As a first step, we have recently introduced thymidine kinase into T. gondii and through this modification have synchronized tachyzoite
populations (24). Experiments are now under way to define
the basic features of the tachyzoite cell cycle.
 |
ACKNOWLEDGMENTS |
We thank John Boothroyd for kindly donating antibodies to SAG1
and David Pascual for supplying the gamma interferon knockout mice used
in these studies.
This work was supported in part by USDA CSREES NRI competitive grants
95-02064 and 97-02461 (M.W.W.) and NIH grants AI-28724 and AI-31808
(D.S.R.). D.S.R. is a Burroughs Wellcome New Investigator in Molecular
Parasitology.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Veterinary
Molecular Biology, Montana State University, Bozeman, MT 59717-0360. Phone: (406) 994-4705. Fax: (406) 994-4303. E-mail:
uvsmw{at}gemini.oscs.montana.edu.
Contribution J-5194 from the Montana State University Agriculture
Experiment Station.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Bohne, W.,
J. Heesemann, and U. Gross.
1993.
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages.
Infect. Immun.
61:1141-1145[Abstract/Free Full Text].
|
| 2.
|
Bohne, W.,
J. Heesemann, and U. Gross.
1994.
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.
Infect. Immun.
62:1761-1767[Abstract/Free Full Text].
|
| 3.
|
Bohne, W.,
U. Gross,
D. J. P. Ferguson, and J. Heesemann.
1995.
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants.
Mol. Microbiol.
16:1221-1230[Medline].
|
| 4.
|
Burg, J. L.,
D. Perelman,
L. H. Kaspar,
P. L. Ware, and J. C. Boothroyd.
1988.
Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii.
J. Immunol.
141:3584-3591[Abstract].
|
| 5.
|
Dalton, D. K.,
M. S. Pitts,
S. Keshav,
I. S. Figari,
A. Bradley, and T. A. Stewart.
1993.
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
Science
259:1739[Abstract/Free Full Text].
|
| 6.
|
Dubey, J. P.
1977.
Toxoplasma, Hammondia, Besnotia, Sarcocystis, and other tissue cyst-forming coccidia of man and animals, p. 101-237.
In
J. P. Krier (ed.), Parasitic protozoa, vol. 3. Academic Press, New York, N.Y.
|
| 7.
|
Dubey, J. P., and J. K. Frenkel.
1972.
Cyst-induced toxoplasmosis in cats.
J. Protozool.
19:155-177[Medline].
|
| 8.
|
Dubey, J. P., and J. K. Frenkel.
1976.
Feline toxoplasmosis from acutely infected mice and the development of Toxoplasma cysts.
J. Protozool.
23:537-546[Medline].
|
| 9.
|
Dubey, J. P., and C. P. Beattie.
1988.
Toxoplasmosis of animals and man.
CRC Press, Inc., Boca Raton, Fla.
|
| 10.
|
Dubey, J. P.,
C. A. Speer,
S. K. Shen,
O. C. H. Kwok, and J. A. Blixt.
1997.
Oocyst-induced murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed Toxoplasma gondii cysts.
J. Parasitol.
83:870-882[Medline].
|
| 11.
|
Fichera, M. E.,
M. K. Bhopale, and D. S. Roos.
1995.
In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii.
Antimicrob. Agents Chemother.
39:1530-1537[Abstract].
|
| 12.
|
Frenkel, J. K.,
J. P. Dubey, and R. L. Hoff.
1976.
Loss of stages after continuous passage of Toxoplasma gondii and Besnoitia jellisoni.
J. Protozool.
23:421-424[Medline].
|
| 13.
|
Frenkel, J. K., and P. Ambroise-Thomas.
1997.
Genomic drift of Toxoplasma gondii.
Parasitol. Res.
83:1-5[Medline].
|
| 14.
|
Freyre, A.,
J. P. Dubey,
D. D. Smith, and J. K. Frenkel.
1989.
Oocyst-induced Toxoplasma gondii infections in cats.
J. Parasitol.
75:750-755[Medline].
|
| 15.
|
Howe, D. K., and L. D. Sibley.
1995.
Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.
J. Infect. Dis.
172:1561-1566[Medline].
|
| 16.
|
Howe, D. K.,
B. C. Summers, and L. D. Sibley.
1996.
Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii.
Infect. Immun.
64:5193-5198[Abstract].
|
| 17.
| Jerome, M. E., and M. W. White.
Unpublished results.
|
| 18.
|
Kaufman, H. E.,
J. S. Remington, and L. Jacob.
1958.
Toxoplasmosis: the nature of virulence.
Am. J. Ophthalmol.
46:255-261[Medline].
|
| 19.
|
Kaufman, H. E.,
M. L. Melton,
J. S. Remington, and L. Jacob.
1959.
Strain differences of Toxoplasma gondii.
J. Parasitol.
45:189-190[Medline].
|
| 20.
| Lindsay, D. S., M. A. Toivio-Kinnucan, and
B. L. Blagburn. Ultrastructural determination of cystogenesis
by various Toxoplasma gondii isolates in cell culture. J. Parasitol. 79:289-292.
|
| 21.
|
Luft, B. J., and J. S. Remington.
1992.
Toxoplasmic encephalitis in AIDS.
Clin. Infect. Dis.
15:211-222[Medline].
|
| 22.
|
Odaert, H.,
M. Soete,
B. Fortier,
D. Camus, and J. F. Dubremetz.
1996.
Stage conversion of Toxoplasma gondii in mouse brain during infection and immunodepression.
Parasitol. Res.
82:28-31[Medline].
|
| 23.
|
Parmley, S. F.,
U. Gross,
A. Sucharczuk,
T. Windeck,
G. D. Sgarlato, and J. S. Remington.
1994.
Two alleles of the gene encoding surface antigen P22 in 25 strains of Toxoplasma gondii.
J. Parasitol.
80:293-301[Medline].
|
| 24.
|
Radke, J., and M. W. White.
1998.
A cell cycle model for the tachyzoite of Toxoplasma gondii using the Herpes simplex virus thymidine kinase.
Mol. Biochem. Parasitol.
94:237-247[Medline].
|
| 25.
|
Ricard, J.,
H. Pelloux,
S. Pathak,
B. Pipy, and P. Ambroise-Thomas.
1996.
TNF- enchances Toxoplasma gondii cyst formation in human fibroblasts through the sphingomyelinase pathway.
Cell Signalling
8:439-442[Medline].
|
| 26.
|
Roos, D. S.,
R. G. K. Donald,
N. S. Morrissette, and A. L. C. Moulton.
1995.
Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii.
Methods Cell Biol.
45:25-61.
|
| 27.
|
Scharton-Kersten, T. M.,
T. A. Wynn,
E. Y. Denkers,
S. Bala,
E. Grunvald,
S. Heiny,
R. T. Gazzinelli, and A. Sher.
1996.
In the absence of endogenous IFN- , mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
J. Immunol.
157:4045-4054[Abstract].
|
| 28.
|
Sibley, L. D., and J. C. Boothroyd.
1992.
Virulent strains of Toxoplasma gondii comprise a single clonal lineage.
Nature (London)
359:82-85[Medline].
|
| 29.
|
Soete, M.,
B. Fortier,
D. Camus, and J. F. Dubremetz.
1993.
Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro.
Exp. Parasitol.
76:259-264[Medline].
|
| 30.
|
Soete, M.,
D. Camus, and J. F. Dubremetz.
1994.
Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro.
Exp. Parasitol.
78:361-370[Medline].
|
| 31.
|
Speer, C. A.,
D. M. Hammond,
J. L. Marhrt, and W. L. Roberts.
1973.
Structure of the oocyst and sporocyst walls and the excystation of sporozoites of Isospora canis.
J. Parasitol.
59:35-40[Medline].
|
| 32.
|
Speer, C. A.,
J. P. Dubey,
J. A. Blixt, and K. Prokop.
1997.
Time lapse video microscopy and ultrastructure of penetrating sporozoites, types 1 and 2 parasitophorous vacuoles, and the transformation of sporozoites to tachyzoites of the VEG strain of Toxoplasma gondii.
J. Parasitol.
83:564-574.
|
| 33.
|
Speer, C. A.,
M. Tilley,
M. E. Temple,
J. A. Blixt,
J. P. Dubey, and M. W. White.
1995.
Sporozoites of Toxoplasma gondii lack dense-granule protein GRA3 and form a unique parasitophorous vacuole.
Mol. Biochem. Parasitol.
75:75-86[Medline].
|
| 34.
|
Tilley, M.,
M. E. Fichera,
M. E. Jerome,
D. S. Roos, and M. W. White.
1997.
Toxoplasma gondii sporozoites form a transient parasitophorous vacuole that is impermeable and contains only a subset of dense-granule proteins.
Infect. Immun.
65:4598-4605[Abstract].
|
Infection and Immunity, October 1998, p. 4838-4844, Vol. 66, No. 10
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bougdour, A., Maubon, D., Baldacci, P., Ortet, P., Bastien, O., Bouillon, A., Barale, J.-C., Pelloux, H., Menard, R., Hakimi, M.-A.
(2009). Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites. JEM
206: 953-966
[Abstract]
[Full Text]
-
Radke, J. R., White, M. W.
(1999). Expression of Herpes Simplex Virus Thymidine Kinase in Toxoplasma gondii Attenuates Tachyzoite Virulence in Mice. Infect. Immun.
67: 5292-5297
[Abstract]
[Full Text]